These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 3328164)

  • 41. The effectiveness of treatments for androgenetic alopecia: A systematic review and meta-analysis.
    Adil A; Godwin M
    J Am Acad Dermatol; 2017 Jul; 77(1):136-141.e5. PubMed ID: 28396101
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Changes in hair weight and hair count in men with androgenetic alopecia, after application of 5% and 2% topical minoxidil, placebo, or no treatment.
    Price VH; Menefee E; Strauss PC
    J Am Acad Dermatol; 1999 Nov; 41(5 Pt 1):717-21. PubMed ID: 10534633
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical utility and validity of minoxidil response testing in androgenetic alopecia.
    Goren A; Shapiro J; Roberts J; McCoy J; Desai N; Zarrab Z; Pietrzak A; Lotti T
    Dermatol Ther; 2015; 28(1):13-6. PubMed ID: 25112173
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Topical minoxidil for male pattern alopecia in two sets of twins.
    Roenigk HH; Kuruvilla S
    Cutis; 1987 Apr; 39(4):329. PubMed ID: 3581904
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An Open-Label Randomized Multicenter Study Assessing the Noninferiority of a Caffeine-Based Topical Liquid 0.2% versus Minoxidil 5% Solution in Male Androgenetic Alopecia.
    Dhurat R; Chitallia J; May TW; Jayaraaman AM; Madhukara J; Anandan S; Vaidya P; Klenk A
    Skin Pharmacol Physiol; 2017; 30(6):298-305. PubMed ID: 29055953
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Is topical minoxidil solution effective on androgenetic alopecia in routine daily practice?
    Mapar MA; Omidian M
    J Dermatolog Treat; 2007; 18(5):268-70. PubMed ID: 17917938
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tretinoin enhances minoxidil response in androgenetic alopecia patients by upregulating follicular sulfotransferase enzymes.
    Sharma A; Goren A; Dhurat R; Agrawal S; Sinclair R; Trüeb RM; Vañó-Galván S; Chen G; Tan Y; Kovacevic M; Situm M; McCoy J
    Dermatol Ther; 2019 May; 32(3):e12915. PubMed ID: 30974011
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mechanism of action of minoxidil in the treatment of androgenetic alopecia is likely mediated by mitochondrial adenosine triphosphate synthase-induced stem cell differentiation.
    Goren A; Naccarato T; Situm M; Kovacevic M; Lotti T; McCoy J
    J Biol Regul Homeost Agents; 2017; 31(4):1049-1053. PubMed ID: 29254313
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Topical minoxidil useful in 18% of patients with androgenetic alopecia: a study of 430 cases.
    Tosti A
    Dermatologica; 1986; 173(3):136-8. PubMed ID: 3770260
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A randomized, double-blind controlled study of the efficacy and safety of topical solution of 0.25% finasteride admixed with 3% minoxidil vs. 3% minoxidil solution in the treatment of male androgenetic alopecia.
    Suchonwanit P; Srisuwanwattana P; Chalermroj N; Khunkhet S
    J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2257-2263. PubMed ID: 29972712
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dose-response study of topical minoxidil in male pattern baldness.
    Olsen EA; DeLong ER; Weiner MS
    J Am Acad Dermatol; 1986 Jul; 15(1):30-7. PubMed ID: 3722507
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The use of minoxidil in the treatment of male and female androgenetic alopecia: a story of more than 30 years.
    Barbareschi M
    G Ital Dermatol Venereol; 2018 Feb; 153(1):102-106. PubMed ID: 29319278
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment of female pattern hair loss with a combination of spironolactone and minoxidil.
    Hoedemaker C; van Egmond S; Sinclair R
    Australas J Dermatol; 2007 Feb; 48(1):43-5. PubMed ID: 17222303
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Topical minoxidil for hair regrowth.
    Vanderveen EE; Ellis CN; Kang S; Case P; Headington JT; Voorhees JJ; Swanson NA
    J Am Acad Dermatol; 1984 Sep; 11(3):416-21. PubMed ID: 6384289
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A randomized trial of minoxidil in chemotherapy-induced alopecia.
    Duvic M; Lemak NA; Valero V; Hymes SR; Farmer KL; Hortobagyi GN; Trancik RJ; Bandstra BA; Compton LD
    J Am Acad Dermatol; 1996 Jul; 35(1):74-8. PubMed ID: 8682968
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Topical tretinoin for hair growth promotion.
    Bazzano GS; Terezakis N; Galen W
    J Am Acad Dermatol; 1986 Oct; 15(4 Pt 2):880-3, 890-3. PubMed ID: 3771854
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of the efficacy and safety of topical minoxidil and topical alfatradiol in the treatment of androgenetic alopecia in women.
    Blume-Peytavi U; Kunte C; Krisp A; Garcia Bartels N; Ellwanger U; Hoffmann R
    J Dtsch Dermatol Ges; 2007 May; 5(5):391-5. PubMed ID: 17451383
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The clinical effect of JetpPeel-assisted topical minoxidil in the treatment of androgenetic alopecia: A randomized pilot study.
    Gong L; Bao L; Tian T; Li Y
    J Cosmet Laser Ther; 2018 Feb; 20(1):58-63. PubMed ID: 29166130
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Histologic response to topically applied minoxidil in male-pattern alopecia.
    Abell E
    Clin Dermatol; 1988; 6(4):191-4. PubMed ID: 3214821
    [No Abstract]   [Full Text] [Related]  

  • 60. Androgenetic alopecia: treatment results with topical minoxidil.
    Roberts JL
    J Am Acad Dermatol; 1987 Mar; 16(3 Pt 2):705-10. PubMed ID: 3549805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.